AlphAIAlphAI — Financial news for AI agents
rttnews.comSEP 42 min read$PDEX

Pro-Dex Jumps On Higher Q4 Earnings And Revenue Growth

Pro-Dex Inc. (PDEX) reported Q4 2026 revenue growth of 17% to $20.41M and net income growth of 140% to $2.86M. Full-year revenue rose 16% to $77.55M, with net income up 52% to $13.66M. Shares surged over 16% following the earnings release.

Original reporting
rttnews.com
Published Sep 4, 2026, 3:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 4:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$PDEX
Bullish
high confidence
Mentioned
$PDEX
Relevance
8/10
AlphAI data visualization · based on rttnews.com
Decision brief

The 30-second read

$PDEXBullishHigh
01

Why it matters

Earnings beat drives a 16% intraday rally, suggesting short‑term buying interest.

02

Market read

First‑report earnings with strong growth and a notable price move make this a high‑value trading story.

03

What to watch

Potential supply‑chain constraints for battery‑powered instruments.

Relevance 8/10Novelty 8/10Timing: post‑earnings release today

Background

Pro‑Dex Inc. reports its Q4 and FY 2026 financials, highlighting revenue growth and profit expansion.

Company-level read

Ticker impact

$PDEXBullishHigh confidence
Context

Q4 earnings and full-year results posted, revenue up 17% YoY and net income up, driving a 16% share jump.

Expected impact

Potential continued rally toward recent highs if momentum persists.

Evidence & confidence

First‑report earnings with double‑digit revenue growth and a sizable same‑day price jump indicate fresh, actionable information.

Market effects

Sector

Positive signal for medical device and surgical instrument sector.

Regional

U.S. biotech/medical device stocks may see modest lift.

Global

Limited to niche medical device space.

Counterpoint

What could challenge this read

Valuation may already price in growth; watch for margin pressure.

Key entities

  • Company
    Pro‑Dex Inc.

    Developer and manufacturer of powered surgical instruments.

Read at source← All news

Also covered by

1 outlet

Related articles

SEP 3
$PDEXMed

PRO DEX INC (PDEX): Quarter Ended June 30, 2026

PRO DEX INC (PDEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Contact: Richard L. Van Kirk, Chief Executive Officer (949) 769-3200 For Immediate Release PRO-DEX, INC. ANNOUNCES FISCAL 2026 FOURTH QUARTER AND FULL-YEAR RESULTS IRVINE, CA, September 3, 2026 - PRO-DEX, INC. (NasdaqCM: PDEX) t oday announced financial results for i

SEC EDGAR 8-K2 min
OCT 25
$NEMHighAI 9/10

Newmont Shares Fall Back, As Gold Price Weakens

Newmont (ASX: NEM) shares fell 4.93% after Q3 results showed revenue of $6.36B and EBITDA of $3.95B, beating estimates, but free cash flow missed by 43%. The company warned of higher costs in Q4. Broader gold sector also declined, with smaller producers hit harder. Gold prices near $4,000/oz.

thebull.com.au3 min
OCT 25
$GOOGLMedAI 8/10

Big Tech Earnings Put AI Returns in Focus Ahead of Fed Decision

Alphabet, Microsoft, and Amazon will report earnings this week, with investors focusing on AI spending returns. The Nasdaq fell 0.21% Friday, and 32% YoY earnings growth is seen in S&P 500 companies. The Fed meets Oct. 27-28, with a 25bps rate hike in September. Meta reported $64.6B Q3 revenue, up 26% YoY, and raised its 2026 cap-ex outlook to $135B-$145B.

econotimes.com2 min
OCT 25
$SPCXMedAI 8/10

SpaceX Could Weather a Recession. But Its Stock Might Not. Here's Why.

SpaceX (SPCX) reported Q3 revenue of $14.6B (+161% YoY) and net income of $4.4B. Starlink, its satellite broadband service, saw 69% YoY revenue growth to $5.2B and 13.6M subscribers. However, average revenue per subscriber fell to $69. The company is investing heavily in AI and other projects, spending $19.6B in Q3. Despite strong business prospects, its high valuation (PS ratio of 64) may make shares vulnerable to market sentiment shifts.

finance.yahoo.com3 min